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ABSTRACT
Insulin resistance and hyperinsulinemia may contribute to the development of
arterial hypertension. Although insulin may elevate arterial pressure, in part,
through activation of the sympathetic nervous system, the sites and mechanisms
of insulin-induced sympathetic excitation remain uncertain. While :
sympathoexeitation during insulin may be mediated by the baroreflex, or by
modulation ofnorepinephrine release from sympathetic nerve endings, it has been
shown repeatedly that insulin increases sympathetic outflow by actions on the :
central nervous system. Previous studies employing norepinephrine turnover have
suggested that insulin causes sympathoexcitation by acting in the hypothalamus.
Recent experiments from our laboratory involving direct measurements of
regional sympathetic nerve activity have provided further evidence that insulin acts
in the central nervous system. For example, administration of insulin into the third
cerebraiventricle increased lumbar but not renal or adrenal sympathetic nerve
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activity in normotensive rats. Interestingly, this pattern of regional sympathetic
nerve responses to central neural administration of insulin is similar to that seen
with systemic administration of insulin. Further, lesions of the anteroventral third
ventricle hypothalamic (AV3V) region abolished increases in sympathetic activity
to systemic administration of insulin with euglycemic clamp, suggesting that
AV3V-related structures are critical for insulin-induced elevations in sympathetic
outflow.
Introduction
Insulin resistance and hyperinsulinemia are frequently associated with
elevated arterial pressure. The coexistence of hyperinsulinemia and hypertension
in obesity (1, 2) and essential hypertension (3, 4) has led to the hypothesis that
insulin plays a major role in the development of arterial hypertension (5, 6). The
prohypertensive actions of insulin include antinatriuresis, trophic effects on
vascular smooth muscle, and activation of muscle sympathetic nerve activity (7,
8).
Insulin-induced sympathetic activation has been suggested as a cause
of arterial pressure elevation. Infusion of insulin during euglycemic clamp
increased plasma norepinephrine levels in experimental animals (9, 10) and in
humans (11-14). Sympathoexcitatory effects of insulin were later confirmed in
investigations directly recording muscle sympathetic nerve activity. Insulin
infusion augmented sympathetic outflow to skeletal muscle in humans (12, 13,
15) and to the hindlimb in normotensive rats (16, 17). The increase inactivity
appeared to be directed to muscle, since no alterations were observed in skin
sympathetic fibers in humans (13), or in renal or adrenal sympathetic activity in
normotensive rats (16).
In rats, a pressor role for insulin-induced sympathetic activation has
been suggested by several studies. For example, insulin-generated elevations in
heart rate and arterial pressure were prevented by ganglionic blockade (18). In
addition, Tomiyama and colleagues (9) chronically infused insulin into Dahl salt-
sensitive and salt-resistant rats. Insulin increased plasma norepinephrine and
arterial pressure in Dahl salt-sensitive rats without affecting either parameter in
Dahl salt-resistant animals. Finally, Kaufman et al. (19) reported that a high fat
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dietelevatedinsulinlevels,urinarynorepinephrine,andarterialpressurein
Sprague-Dawleyrats.
In contrastto responsesin rats,studiesin humanshavenotbeenable
to establishaclearlink betweensympathoexcitation,i creasesinvascular
resistanceandarterialpressure.Acuteadministrationof physiolo_c
concentrationsofinsulininnormotensivehumanselevatedsympatheticactivity
withoutincreasingarterialpressure,in fact,short-terminsulinadministration
typicallyproducedacomplexpatternof responses,consistingof increased
sympatheticnerveactivity,elevatedheartrate,skeletalmusclevasodilation,andno
changeor evenslightdecrementsin bloodpressure(12-15,20).
Thefailureof acuteinsulin-inducedsympathoexcitationto elevate
arterialpressureinhumansdoesnotexcludethepossibilityof long-term
sympatheticeffectsonpressureregulation.Forexample,bothsympathetic
stimulation and norepinephrine treatment accelerate growth and polyploidy of
vascular smooth muscle cells (21-23). These effects could combine with the
vascular trophic influences of insulin (24) to promote structural alterations of
arterial vessels, thereby reducing the lumen, amplifying vasoconstrictor responses
to contractile agents, and promoting the development of hypertension.
This review will briefly examine the mechanisms of insulin-induced
activation of the sympathetic nervous system. While it has been hypothesized that
sympathoexcitation to hyperinsulinemia is mediated through stimulation of
carbohydrate metabolism, release of norepinephrine from sympathetic fibers, or
by the baroreflex, it seems more likely that insulin alters neuronal activity in the
central nervous system which causes increases in sympathetic neural outflow.
]Indirect Mechanisms of Sympathetic Neural Activation
Insulin may influence sympathetic outflow through indirect actions of
the hormone on metabolic and cardiovascular regulation. Vollenweider and
colleagues (15) proposed that insulin elevates sympathetic activity through
stimulation of carbohydrate metabolism and oxidation. To test this hypothesis,
Vollenweider et al. infused insulin and fructose into normotensive humans.
Whereas insulin and fructose produced comparable increases in carbohydrate
42 MUNTZEL ET AL.
metabolism, only insulin elevated sympathetic nerve activity. Thus,
hyperinsulinemia per se and not increased carbohydrate oxidation appears to be the
main mechanism triggering sympathetic excitation.
A second indirect mechanism of sympathetic stimulation is related to
the vasodilatory effects of infused insulin (7, 20). Insulin-induced vasodilation in
skeletal muscle can lead to small decreases in arterial pressure, thereby inducing
baroreceptor-mediated increases in sympathetic activity (7, 13-15). However, in
several human studies, euglycemic hyperinsulinemia elevated sympathetic activity
without decreasing arterial pressure (11, 13, 14, 25). Nevertheless, in such
studies, there may have been transient, undetectable decreases in arterial pressure
which were sufficient to engage the baroreflex. In contrast to these experiments,
we observed small but significant decreases in diastolic blood pressure during
infusion of insulin (12). However, the increase in muscle sympathetic nerve
activity was larger than would be expected for such a small decrease in diastolic
pressure. In addition, the rapid decrease in diastolic pressure did not temporally
coincide with the slower increase in muscle sympathetic nerve activity (12).
Further disfavoring a baroreceptor mechanism, we recently demonstrated in rats
that direct central neural administration of insulin elevated lumbar sympathetic
nerve activity in the absence of changes in plasma insulin (26). Because central
neural insulin increased sympathetic outflow without altering systemic insulin
levels, and presumably in the absence ofvasodilation, it appears that insulin can
activate sympathetic outflow independently ofvasodilation and engagement of the
baroreflex.
Direct Neural Mechanisms
Insulin may evoke sympathetic activation through a number of direct
mechanisms. For instance, insulin may affect norepinephrine release from
adrenergic nerve endings (9, 18). Countering this possibility, Lembo et al. (14)
failed to detect increases in forearm norepinephrine levels during local insulin
infusion in humans. The fact that only systemic insulin administration increased
n0repinephrine release suggested that the sympathoexcitatory effects were
mediated by a central neural mechanism (14).
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Landsberg(6)andothers(11)suggestedasympathoexcitatoryoleof
insulin in the central nervous system. In an early study, a low dose of insulin
injected into the carotid arteries of dogs increased blood pressure before a fall in
blood glucose (27). A relationship between insulin sensitive regions in the
hypothalamus and sympathetic activity was later established in experiments using
gold thioglucose in mice (28). In these studies, changes in cardiac norepinephrine
turnover during feeding and caloric restriction were abolished by gold thioglucose
lesions of the ventromedial hypothalamus, suggesting that hypothalamic regions
provide an important link between insulin-mediated glucose metabolism and
sympathetic nervous system activity.
Results from euglycemic clamp studies in humans point to a
mechanism of insulin delivery into the central nervous system. In these
experiments, plasma norepinephrine and sympathetic nerve activity continued to
rise even after plasma insulin levds were at a steady state level or declining (11,
12, 15). These data suggest that insulin may have to reach the interstitial space or
a nonvascular third compartment to exert its excitatory effects (11, 12, 15). In this
regard, Schwartz and colleagues (29) observed a 30 min delay before euglycemic
hyperinsulinemia produced a rise in cerebrospinal (CSF) levels of insulin in dogs.
The delayed entry of blood-borne insulin into the CSF is best explained by the
passage of insulin into the brain interstitial fluid via a saturable, insulin receptor-
mediated transport process (30, 31).
Once delivered into central neural tissues, insulin may bind with
receptors located in several brain areas. For example, autoradiographic studies
have identified insulin-specific binding sites in the median eminence (32, 33), the
dorsomedial hypothalamus, the areuate nucleus, and in the ventromedial
hypothalamus (34).
We have been evaluating the sympathetic effects of
intracerebroventrieular infusion of insulin. In normotensive Sprague-Dawley rats,
administration of insulin into the third cerebralventricle increased lumbar
sympathetic nerve activity (26). Interestingly, central neural administration of
insulin failed to significantly increase renal or adrenal sympathetic nerve activity
(35). This pattern of sympathetic excitation, that is, increased lumbar activity with
no change in renal or adrenal outflow, is precisely the same type of activation
44 MUNTZEL ET AL.
Intravenous Intracerebroventricular
2OO
Lumbar f _t_,_ . _l_,_,_f 0
Renal
SNA
(Hz)
200_
1001-,. ,.I ,,,_ ,. i
2°°FAdrenal . .
SNA 1001-- , . _..J,J._,,..J._i.,..., ,h' , _,...
Baseline Insulin Baseline Insulin
0.13 U/hr 6.0 U/hr
2 m_
FIG. 1. Segments of original records from normotensive rats showing responses
of lumbar, renal, and adrenal sympathetic nerve activity (SNA) to intravenous and
intracerebroventricular insulin. The two left columns show SNA during baseline
and the last 3 min of 120 min infusions of intravenous insulin (60 min at 0.06
U/hr followed by 60 min at 0.13 U/hr). The two right columns show SNA during
baseline and the last 3 min of 50 min infusion of insulin into the third
cerberalventricle. Administration of insulin either systemically or into the brain
increased lumbar SNA (top) but failed to affect renal SNA (middle) or adrenal
SNA (bottom).
observed when insulin is administered systemically during euglycemic clamp (see
Figure 1). Thus, direct central neural administration of insulin generates a pattern
of sympathetic activation similar to that produced by systemic insulin. These data
strongly suggest that hyperinsulinemia produces sympathetic excitation through
effects on the centzal nervous system.
We reasoned that if infusion of insulin into the third cerebralventricle
increases lumbar nerve activity, destruction of third ventricular structures should
abolish increases in sympathetic outflow to systemic euglycemic hyperinsulinemia
(17). To test this hypothesis, we subsequently lesioned tissues surrounding the
anteroventral portion of the third ventricle (AV3V), a region clearly implicated in
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FIG. 2. The top bar graph shows percentage increases in lumbar SNA after 120
rain infusions of intravenous insulin (60 rain at 0.06 U/hr followed by 60 min at
0.13 U/hr) in sham-lesioned rats and in rats that had received lesions of the
anteroventral third ventricle (AV3V) region. During hyperinsulinemia, lumbar
SNA increased substantially in sham-lesioned rats but only slightly in AV3V-
lesioned rats (* p < 0.01, sham lesion vs. AV3V lesion). In fact, sympathetic :
elevations in AV3V-lesioned rats were no greater than increases observed in
vehicle-infused rats (data not shown). The graph on the bottom shows the
percent increase in lumbar SNA per maximum decreases in mean arterial pressure
(MAP) induced by nitroglycerin. AV3V lesions did not affect baroreceptor-
mediated increases in lumbar SNA.
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arterial pressure regulation and sympathetic neural control (36). Intravenously
administered insulin produced a typical increase in lumbar sympathetic nerve
activity in sham-lesioned rats (Figure 2, top). In contrast, AV3V-lesioned rats
showed markedly diminished elevations in sympathetic activity to systemic
insulin. In fact, the sympathetic increases in the lesioned group were no greater
than increases observed in vehicle-infused rats (data not shown). AV3V lesions,
therefore, abolished elevations in sympathetic activity to systemic
hyperinsulinemia.
We considered that systemic insulin treatment may have produced
vasodilation and activation of the baroreceptor reflex. Therefore, AV3V lesions
may have reduced sympathetic responses to insulin simply by interrupting part of
the baroreceptor reflex arc. To test this possibility, sham-lesioned and AV3V-
lesioned animals were analyzed for lumbar responses to nitroglycerin-induced
hypotension (Figure 2, bottom). AV3V lesions did not affect increases in
sympathetic activity to a given fall in blood pressure. Therefore, destruction of the
AV3V region does not produce non-specific depression to sympathoexcitatory
stimuli.
In summary, these studies provide important evidence supporting the
concept that insulin acts within the central nervous system to increase sympathetic
activity. Further, they suggest that AV3V-related structures are critical for insulin-
induced elevations in sympathetic outflow. In light of these findings, it should be
remembered that AV3V lesions protect against several forms of experimental
hypertension (37). Our demonstration of decreased sympathetic activation to
insulin in AV3V-lesioned rats suggests a role for the AV3V region in
hypertension characterized by insulin resistance and hyperinsulinemia.
Acknowledgments: This research was supported in part by a National Research
Service Award HL-08704 and National Institutes of Health Grants HL-14338 and
HL-44546 from the National Heart, Lung, and Blood Institute, and by research
funds from the Department of Veterans Affairs.
INSULINANDSYMPATHETICACTIVITY 47
REFERENCES
1. Lucas,C.P.,Estigarribia,J.A.,Darga,L., Reaven,G.M.Insulinand
bloodpressurein obesity.Hypertension.1985;7: 702-706.
2. Modan,M., Haikin,H., Almog,S.,Lusky,A., Eshkol,A., Shefi,M.,
Shitrit,A., Fuchs,Z. Hyperinsulinemia:a link betweenhypertension,obesity,and
glucoseintolerance.JClin Invest.1985;75:809.
3. Bonora,E.,Zavaroni, I., Aipi, O., Pazzarossa, A., Bruschi, F.,
Dall'Aglio, E., Guerra, L., Coscelli, C., Butturini, U. Relationship between blood
pressure and plasma insulin in non-obese and obese non-diabetic subjects.
Diabetetologia. 1987; 30:719-723.
4. Swislocki, A.L.M., Hoffman, B.B., Reaven, G.M. Insulin resistance,
glucose intolerance and hyperinsulinemia in patients with hypertension. Am J
Hypertens. 1989; 2: 419-423.
5. Reaven, G.M. Role of insulin resistance in human disease. Diabetes.
1988; 37: 1595-1607.
6. Landsberg, L., Krieger, D.R. Obesity, metabolism, and the
sympathetic nervous system. Am J Hypertens. 1989; 2: 125S-132S.
7. Anderson, E.A., Mark, A.L. The vasodilator action of insulin.
Implications for the insulin hypothesis of hypertension. Hypertension. 1993; 21:
136-141.
8. Reaven, G.R. Insulin resistance, hyperinsulinemia, and
hypertriglyeeridemia in the etiology and clinical course of hypertension. Am J
Med. 1991; 90 (suppl. 2A): 2A-7S-2A-12S.
9. Tomiyama, H., Abeta, T., Kurumatani, H., Taguchi, H., Kuga, N.,
Saito, F., Kobayashi, F., Otsuka, Y., Kanmatsuse, K., Kajiwara, N. Blood
pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats.
Hypertension. 1992; 20: 596-600.
10. Liang, C.S., Doherty, J.U., Faillace, R., Maekawa, K., Arnold, S.,
Garvas, H., Hood, W.B. Insulin infusion in conscious dogs. J Clin Invest. 1982;
69: 1321-1336.
48 MUNTZEL ET AL.
11. Rowe, J.W., Young, J.B., Minaker, K.L., Stevens, A.L., Pallotta, J.,
Landsberg, L. Effect of insulin and glucose infusions on sympathetic nervous
system activity in normal man. Diabetes. 1981; 30: 219-225.
12. Anderson, E.A., Hoffman, R.P., Balon, T.W., Sinkey, C.A., Mark,
A.L. Hyperinsulinemia produces both sympathetic neural activation and
vasodilation in normal humans. J Clin Invest. 1991; 87: 2246-2252.
13. Berne, C., Fagius, J., Pollare, T., Hjemdahl, P. The sympathetic
response to euglycaemic hyperinsulinemia. Evidence from microelectrode nerve
recordings in healthy subjects. Diabetologia. 1992; 35: 873-879.
14. Lembo, G., Napili, R., Capaldo, B., Redina, V., Laccarino, G., Volpe,
M., Trimarco, B., Sacca, L. Abnormal sympathetic overactivity evoked by insulin
in the skeletal muscle of patients with essential hypertension. J Clin Invest. 1992;
90: 24-29.
15. Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., J6quier, E.,
Nicod, P., Scherrer, U. Differential effects of hyperinsulinemia and carbohydrate
metabolism on sympathetic nerve activity and muscle blood flow in humans. J
Clin Invest. 1993; 92: 147-154.
16. Morgan, D.A., Balon, T.W., Ginsberg, B.H., Mark, A.L. Nonuniform
regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol.
1993; 264: R423-R427.
17. Muntzel, M.S., Mark, A.L., Johnson, A.K. Anteroventral third
ventricle lesions abolish sympathetic neural responses to hyperinsulinemia.
Hypertension (in press).
18. Edwards, J.G., Tipton, C.M. Influences of exogenous insulin on
arterial blood pressure measurements of the rat. J Appl Physiol. 1989; 67(6):
2335-2342.
19. Kaufman, L.N., Peterson, M.M., Smith, S.M. Hypertension and
sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am J
Physiol. 1991; 260: E95-E100.
20. Baron, A.D., Brechtel-Hook, G., Johnson, A., Hardin, D. Skeletal
muscle blood flow. A possible link between insulin resistance and blood pressure.
Hypertension. 1993; 21: 129-135.
INSULINANDSYMPATHETICACTIVITY 49
21. Bevan,R.D.Trophiceffectsof peripheraladrenergicnerveson
vascularstructure.Hypertension.1984;6(Suppl.III): III 19-II126.
22. Blaes,N.A.,Boissel,J.P.Growth-stimulatingeffectof catecholamines
onrataorticsmoothmusclecellsin culture.J CellPhysiol.1983;116:167-172.
23. Yamori,Y.,Mano,M., Nara,Y., Horie,R.Catecholamine-inducded
polyploidizationinvascularsmoothcell.Circulation.1987;75(Suppl.1):I192-
1195.
24. Stout,R.W.,Bierman,E.L.,Ross,R.Effectof insulinonthe
proliferationof culturedprimatearterialsmoothmusclecells.Circ Res.1975;36:
319-327.
25. Rocchini,A.P.,Katch,V., Kveselis,D.,Moorehead,C.,Martin,M.,
Lampman,R.,Gregory,M. Insulinandrenalsodiumretentionin obese
adolescents.Hypertension.1989;14:367-374.
26. Muntzel,M., Morgan,D.,Mark,A.L., Johnson,A.K. lntraventricular
insulinincreaseslumbarsympatheticnerveactivity.FASEBJoumanl.1993;7:
A532.
27. Pereda,S.A.,J.W.,E.,Abboud, F.M. Cardiovascular responses to
insulin in the absence of hypoglycemia. Am J Physiol. 1962; 202: 249-252.
28. Young, J.B., Landsberg, L. Impaired suppression of sympathetic
activity during fasting in the gold thioglucose-treated mouse. J Clin Invest. 1980;
65: 1086-1094.
29. Schwartz, M.W., Sipois, A.J., Kahn, S.E., Lattemann, D.P.,
Taborsky, G.J., Jr., Bergman, R.N., Porte, D., Jr. Kinetics and specificity of
insulin uptake from plasma into eerebrospinal fluid. Am J Physiol. 1990; 259:
E378-E383.
30. Baura, G.D., Foster, D.M., Porte, J., D., Kahn, S.E., Bergman, R.N.,
Cobelli, C., Schwartz, M.W. Saturable transport of insulin from plasma into the
central nervous system of dogs in vivo. J Clin Invest. 1993; 92: 1824-1830.
31. Schwartz, M.W., Bergraan, R.N., Kahn, S.E., Taborsky, G.J., Jr.,
Fisher, L.D., Sipols, A.J., Woods, S.C., Steil, G.M., Porte, D., Jr. Evidence for
5O MUNTZEL ET AL.
entry of plasma insulin into cerebrospinal fluid through an intermediate
compartment in dogs. J Clin Invest. 1991; 88: 1272-1281.
32. Landau, B.R., Takaoka, Y., Abrams, M.A., M., G.S., van Houten,
M., Posner, B.I., White, R.J., Ohgaku, S., Horvat, A., Hemmelgarn, E. Binding
of insulin by monkey and pig hypothalamus. Diabetes. 1983; 32: 284-292.
33. van Houten, M., Posner, B.I., Kopriwa, B.M., Brawer, J.R. Insulin-
binding sites in the rat brain: in vivo localization to the circumventricular organs by
quantitative radioautography. Endocrinology. i 979:105: 666-673.
34. Wilcox, B.J., Corp, E.S., Dorsa, D.M., Figlewicz, D.P., Greenwood,
M.R., Woods, S.C., Baskin, D.G. Insulin binding in the hypothalamus of lean and
genetically obese Zucker rats. Peptides. 1989; 10: ! 159-1164.
35. Muntzel, M.S., Morgan, D.A., Mark, A.L., Johnson, A.K.
Intracerebroventricular (icv) insulin produces specific activation of lumbar
sympathetic nerve activity. Soc Neurosci. Abstracts. 1993; 19: 434.
36. Johnson, A.K., Gross, P.M. Sensory circumventricular organs and
brain homeostatic pathways. FASEB Journal. 1993; 7: 678-686.
37. Brody, M.J., Johnson, A.K., Frontiers in Neuroendocrinology, L.
Martini and W.F. Ganong, Vol 6, Raven Press, New York, 1980, pp 249-292.
